Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Mears Group acquires Care UK’s domiciliary care service for £11.3m

Support services firm Mears Group has bought Care UK’s home care division, as was first reported by HealthInvestor, for a sum of £11.3 million.

The purchase price comprises of a base payment of £9 million with a further payment of £2.3 million made in respect of cash balances and excess working capital acquired on completion.

Care UK’s home care service looks after approximately 13,000 people across the UK and employs around 6,000 staff members.

For the year ended 30 September 2014, it reported revenues of £72.2 million and an operating loss before exceptional items of £2.6 million.

In a statement, Mears said Care UK had already started closing some branches of the domiciliary care business because of “particularly poor results in certain regions”.

The acquired assets will be renamed Mears Care and the management team will remain the same.

David Miles, chief executive of Mears Group (pictured), said: "I believe we have acquired one of our most significant competitors at an attractive valuation. Our focus will be upon enhancing service delivery thus enabling financial improvements.”

The acquisition  marks the completion of Care UK’s divestment strategy, which also saw it sell off its mental health and learning disability divisions. The private care provider has said it plans focus solely primary and secondary NHS health services and residential and nursing homes.

In May, Care UK sold its mental health assets, comprising of 322 beds, to Partnerships in Care for an undisclosed sum. It also sold its learning disability services group to Lifeways in the same month.

According to a press release, the three transactions, which had a combined annual ebitda of £12.9 million last year, have generated £130 million (before fees and expenses) for Care UK.

Mike Parish, chief executive of Care UK, said: “We are pleased to have reached very positive outcomes for patients and services users, colleagues and commissioners in all three services. The strategic review process which is now completed strengthens Care UK’s positioning for future growth within both the health and social care sectors.”

Rothschild advised Care UK on its divestments.


Related articles:

Posted on: 01/06/2015

Latest news stories

11/11/2019
Swisslog Healthcare, a supplier of solutions for medication management in healthcare, has purchased TheraPick by Cleveland Clinic London.
11/11/2019
Councils will need billions of pounds in additional funding to meet the rising costs of social care, according to the Institute of Fiscal Studies.
11/11/2019
Record numbers of NHS patients are being treated in private hospitals, new figures reveal, fuelling controversy over health service “privatisation” in the run-up to the general election.
11/11/2019
Sapphire Medical Clinics has welcomed the National Institute for Health and Care Excellence decision to make cannabis-based Sativex available on the NHS in particular circumstances.
08/11/2019
Target Healthcare has agreed the acquisition of eight care homes and 31 retirement apartments for the total consideration of £81.3 million.


Civica


HealthInvestor blog
Four Seasons Health Care is the UK’s second-largest care home operator with around 16,000 vulnerable residents dependent on it for a place to live.

Click here to view the HealthInvestor blog


Mental health is finally receiving the attention it deserves, but private organisations have been slow to recognise the issue and the opportunities it presents. Encouragingly, there are now signs that businesses are starting to react, and investment is beginning to follow, says Niamh Buckley, associate at global M&A firm Livingstone
Real estate specialists Knight Frank’s head of healthcare, Julian Evans, reviews UK care home trading performance
While numerous companies have emerged to offer genetic testing direct to the consumer, one area of the field has received relatively little attention. Rob Munro talks to a young entrepreneur making waves in the exciting new science of epigenetics
Recently announced deals between GenesisCare and Spire Healthcare intend to create a joined up, end-to-end treatment pathway for private cancer patients and could form the basis for further co-operation says Catherine Gooderham
Kathy Oxtoby talks to two key leaders at neuro-rehabilitation services specialist Christchurch Group about the challenges they face, the company’s ethos, and the opportunities available for investors in the business

Click here to search all feature articles



Digital primary care

Earlier this year, the UK digital primary care market felt full of potential for investors but who are the players and what are the products that stand out now that the dust has settled? Kathy Oxtoby investigates
Read more


Christie + Co

my images



Domiciliary Care
Rob Munro talks to the head of one of the country's leading domiciliary care providers about challenges and opportunities in a sector where many companies have foundered
Read more